Informationen:
Fehler:
ID
29706
Beschreibung
A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection; ODM derived from: https://clinicaltrials.gov/show/NCT00720434
Link
https://clinicaltrials.gov/show/NCT00720434
Stichworte
Versionen (1)
- 14.04.18 14.04.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
14. April 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Hepatitis C NCT00720434
Eligibility Hepatitis C NCT00720434
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Hepatitis C NCT00720434
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Therapy naive | Interferon-alpha Absent | Ribavirin Absent
Item
treatment naive (no prior treatment with ifn-a +/- rbv regimens.
boolean
C0919936 (UMLS CUI [1])
C0002199 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0035525 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0002199 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0035525 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Interferon-alpha Discontinued | Drug Tolerance Issue
Item
subjects who have discontinued ifn-a containing regimens after <2 weeks of therapy due to tolerability issues are considered treatment naive.
boolean
C0002199 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0013220 (UMLS CUI [2,1])
C0033213 (UMLS CUI [2,2])
C1444662 (UMLS CUI [1,2])
C0013220 (UMLS CUI [2,1])
C0033213 (UMLS CUI [2,2])
Hepatitis C virus RNA assay
Item
hcv rna > 100,000 iu/ml at screening.
boolean
C1272251 (UMLS CUI [1])
Genotype determination
Item
genotype 1.
boolean
C1533728 (UMLS CUI [1])
Hepatitis C, Chronic
Item
a diagnosis of chronic hcv infection for at least 6 months.
boolean
C0524910 (UMLS CUI [1])
HIV Infection | Hepatitis B | Chronic infection with HIV | Hepatitis B, Chronic
Item
evidence of acute or chronic infection with hiv or hbv.
boolean
C0019693 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0853112 (UMLS CUI [3])
C0524909 (UMLS CUI [4])
C0019163 (UMLS CUI [2])
C0853112 (UMLS CUI [3])
C0524909 (UMLS CUI [4])
Exposure to Investigational New Drugs Against Hepatitis C virus
Item
exposure within the previous three months to an investigational anti-hcv agent.
boolean
C0332157 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0521124 (UMLS CUI [1,3])
C0220847 (UMLS CUI [1,4])
C0013230 (UMLS CUI [1,2])
C0521124 (UMLS CUI [1,3])
C0220847 (UMLS CUI [1,4])
Liver disease Severe | Decompensated liver disease
Item
evidence of severe or decompensated liver disease.
boolean
C0023895 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C4075847 (UMLS CUI [2])
C0205082 (UMLS CUI [1,2])
C4075847 (UMLS CUI [2])
Liver disease | Exception Hepatitis C
Item
subjects with liver disease unrelated to hcv infection.
boolean
C0023895 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0019196 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0019196 (UMLS CUI [2,2])